| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/09/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 54.1k | $37.00 | $2M | | 08/09/2023 |
| 06/22/2023 | Acrivon Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 32.5k | $12.88 | $418.6k | | 06/22/2023 |
| 06/15/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Common Stock | 19.6k | $0.00 | $0 | | 06/15/2023 |
| 06/15/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to buy) | 27.4k | $2.47 | $67.6k | | 06/15/2023 |
| 06/08/2023 | PMV Pharmaceuticals, Inc. | PMVP | Grant | Stock Option (right to buy) | 21.5k | $5.59 | $120.2k | | 06/08/2023 |
| 01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Employee Stock Option (Right to Buy) | 7.5k | $45.66 | $343.4k | | 01/20/2023 |
| 01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 4.4k | $0.00 | $0 | | 01/20/2023 |
| 01/04/2023 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 3.6k | $46.60 | $170k | | 01/04/2023 |
| 12/21/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 9.1k | $40.42 | $367.5k | | 12/19/2022 |
| 12/19/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 53.6k | $0.00 | $0 | | 12/19/2022 |
| 11/28/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 69.3k | $100.00 | $6.9M | | 11/28/2022 |
| 11/28/2022 | Mirati Therapeutics, Inc. | MRTX | Exercise | Employee Stock Option (Right to Buy) | 69.3k | $17.41 | $1.2M | | 11/28/2022 |
| 06/16/2022 | Poseida Therapeutics, Inc. | PSTX | Grant | Common Stock | 39.3k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to Buy) | 57k | $2.01 | $114.6k | | 06/16/2022 |
| 06/02/2022 | PMV Pharmaceuticals, Inc. | PMVP | Grant | Stock Option (right to buy) | 19.5k | $13.56 | $264.4k | | 06/02/2022 |
| 01/18/2022 | Mirati Therapeutics, Inc. | MRTX | Exercise | Employee Stock Option (Right to Buy) | 3.7k | $27.00 | $100k | | 01/14/2022 |
| 01/18/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 2.5k | $120.48 | $303.3k | | 01/14/2022 |
| 01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 25.5k | $0.00 | $0 | | 01/14/2022 |
| 01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Employee Stock Option (Right to Buy) | 42.3k | $124.31 | $5.3M | | 01/14/2022 |
| 01/04/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 4k | $147.73 | $597.6k | | 01/04/2022 |
| 01/04/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 69 | $149.09 | $10.3k | | 01/04/2022 |
| 12/16/2021 | Mirati Therapeutics, Inc. | MRTX | Gift | Common Stock | 7.4k | $0.00 | $0 | | 12/16/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 9.2k | $131.61 | $1.2M | | 12/03/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 21.5k | $132.49 | $2.8M | | 12/03/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 3.9k | $133.27 | $519.7k | | 12/03/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 3.8k | $134.57 | $517k | | 12/03/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 6.6k | $135.64 | $889.5k | | 12/03/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1.2k | $136.66 | $165.4k | | 12/03/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 985 | $137.56 | $135.5k | | 12/03/2021 |
| 12/03/2021 | Mirati Therapeutics, Inc. | MRTX | Exercise | Employee Stock Option (Right to Buy) | 47.2k | $8.49 | $400.8k | | 12/03/2021 |
| 06/18/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 4.8k | $164.07 | $790.2k | | 06/18/2021 |
| 06/18/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 13.3k | $164.90 | $2.2M | | 06/18/2021 |
| 06/18/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 20.8k | $166.07 | $3.5M | | 06/18/2021 |
| 06/18/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1k | $166.73 | $170.6k | | 06/18/2021 |
| 06/18/2021 | Mirati Therapeutics, Inc. | MRTX | Exercise | Employee Stock Option (Right to Buy) | 40k | $8.49 | $339.6k | | 06/18/2021 |
|